These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27803245)

  • 1. Modulation of prion polymerization and toxicity by rationally designed peptidomimetics.
    Srivastava A; Sharma S; Sadanandan S; Gupta S; Singh J; Gupta S; Haridas V; Kundu B
    Biochem J; 2017 Jan; 474(1):123-147. PubMed ID: 27803245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights into the critical role of gallate moiety of green tea catechins in modulating prion fibrillation, cellular internalization, and neuronal toxicity.
    Admane N; Srivastava A; Jamal S; Sharma R; Kundu B; Grover A
    Int J Biol Macromol; 2022 Dec; 223(Pt A):755-765. PubMed ID: 36368361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural facets of disease-linked human prion protein mutants: a molecular dynamic study.
    Rossetti G; Giachin G; Legname G; Carloni P
    Proteins; 2010 Dec; 78(16):3270-80. PubMed ID: 20806222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of the conserved tyrosine in the β2-α2 loop of the prion protein.
    Huang D; Caflisch A
    Prion; 2015; 9(6):412-9. PubMed ID: 26689486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing the denatured state of human prion 121-230.
    Lee CI; Chang NY
    Biophys Chem; 2010 Sep; 151(1-2):86-90. PubMed ID: 20627399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics studies on the buffalo prion protein.
    Zhang J; Wang F; Chatterjee S
    J Biomol Struct Dyn; 2016; 34(4):762-77. PubMed ID: 26043781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disaggregation mechanism of prion amyloid for tweezer inhibitor.
    Rahman MU; Rehman AU; Arshad T; Chen HF
    Int J Biol Macromol; 2021 Apr; 176():510-519. PubMed ID: 33607137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition Mechanisms between a Nanobody and Disordered Epitopes of the Human Prion Protein: An Integrative Molecular Dynamics Study.
    Mollica L; Giachin G
    J Chem Inf Model; 2023 Jan; 63(2):531-545. PubMed ID: 36580661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the N-terminal β-sheet conversion in the crystal structure of the human prion protein bound to a nanobody.
    Abskharon RN; Giachin G; Wohlkonig A; Soror SH; Pardon E; Legname G; Steyaert J
    J Am Chem Soc; 2014 Jan; 136(3):937-44. PubMed ID: 24400836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Prion-like Aggregation of Mutant p53 to Combat Cancer.
    Silva JL; Cino EA; Soares IN; Ferreira VF; A P de Oliveira G
    Acc Chem Res; 2018 Jan; 51(1):181-190. PubMed ID: 29260852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal Prion Protein Peptides (PrP(120-144)) Form Parallel In-register β-Sheets via Multiple Nucleation-dependent Pathways.
    Wang Y; Shao Q; Hall CK
    J Biol Chem; 2016 Oct; 291(42):22093-22105. PubMed ID: 27576687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics study of the dominant-negative E219K polymorphism in human prion protein.
    Jahandideh S; Jamalan M; Faridounnia M
    J Biomol Struct Dyn; 2015; 33(6):1315-25. PubMed ID: 25027605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational Switching and Nanoscale Assembly of Human Prion Protein into Polymorphic Amyloids via Structurally Labile Oligomers.
    Dalal V; Arya S; Bhattacharya M; Mukhopadhyay S
    Biochemistry; 2015 Dec; 54(51):7505-13. PubMed ID: 26645611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into structural properties of denatured human prion 121-230 at melting temperature studied by replica exchange molecular dynamics.
    Tang JL; Wu PJ; Wang SC; Lee CI
    J Phys Chem B; 2012 Mar; 116(10):3305-12. PubMed ID: 22339436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymerization of human prion peptide HuPrP 106-126 to amyloid in nucleic acid solution.
    Nandi PK
    Arch Virol; 1998; 143(7):1251-63. PubMed ID: 9722872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231.
    Apetri AC; Vanik DL; Surewicz WK
    Biochemistry; 2005 Dec; 44(48):15880-8. PubMed ID: 16313190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of prion inhibition by phenothiazine compounds.
    Baral PK; Swayampakula M; Rout MK; Kav NN; Spyracopoulos L; Aguzzi A; James MN
    Structure; 2014 Feb; 22(2):291-303. PubMed ID: 24373770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic amyloidogenicity of mammalian prion proteins from species susceptible and resistant to prions.
    Nyström S; Hammarström P
    Sci Rep; 2015 May; 5():10101. PubMed ID: 25960067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of GNNQQNY prion peptide aggregation by trehalose: a mechanistic view.
    Katyal N; Deep S
    Phys Chem Chem Phys; 2017 Jul; 19(29):19120-19138. PubMed ID: 28702592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Effects of a Neurohypophyseal Hormone Analogue on Prion Aggregation, Cellular Internalization, and Toxicity.
    Admane N; Srivastava A; Jamal S; Kundu B; Grover A
    ACS Chem Neurosci; 2020 Aug; 11(16):2422-2430. PubMed ID: 31407881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.